Growth Hormone Programs

  • Norditropin® (somatropin) injection 5 mg, 10 mg, 15 mg, 30 mg pens
  • Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, 15 mg pens

Patient Assistance Program (PAP) Eligibility Requirements:

Patients who meet program eligibility criteria and financial need requirements are eligible to receive a free supply of Sogroya® or Norditropin® for up to one (1) year with requalification process to occur thirty (30) days prior to PAP expiration.

  • You must be a US citizen or legal resident
  • Your total household income must be at or below 400% of the federal poverty level (FPL) after inclusion of Sogroya® or Norditropin® estimated cost deduction. Visit the NeedyMeds website, which lists the current FPL guidelines
  • You must have been prescribed therapy for a diagnosis that is an FDA-approved indication for Sogroya® or Norditropin®
  • You cannot have or qualify for government benefit coverage, including any federal, state, or local program such as Medicare or Medicaid:
    • Exceptions include:
      • Government beneficiary with diagnosis or therapy exclusion
      • Patients who are eligible for Department of Veterans Affairs (VA) prescription benefits or Medicaid must have applied for and been denied enrollment, including exhaustion of all appeals
      • Patients who are Medicare eligible and do not have Medicare Part D coverage who have applied for and been denied Extra Help/Low Income Subsidy (LIS). To apply for LIS, please contact the Social Security Administration at 1‑800‑772‑1213 (TTY 1‑800‑325‑0778) or go to ssa.gov/benefits/medicare/prescriptionhelp/

JumpStart™ and Interim Program eligibility

Patients who have been prescribed Sogroya® or Norditropin® for an FDA-approved indication and who have commercial insurance may be eligible to receive a limited supply of free product from JumpStart™ or the Interim Program. Patients who participate in any government, state, or federally funded medical or prescription benefit programs, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance, are not eligible to participate in JumpStart™ or the Interim Program.

JumpStart™ and Interim Program product is provided at no cost to the patient or the HCP, is not contingent on any product purchase, and the patient and HCP must not: (1) bill any third party for the free product, or (2) resell the free product.